Related references
Note: Only part of the references are listed.SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium
Rebecca Marlow et al.
CANCER RESEARCH (2008)
The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer
Lingbao Ai et al.
CARCINOGENESIS (2008)
A novel brain-enriched E3 ubiquitin ligase RNF182 is up regulated in the brains of Alzheimer's patients and targets ATP6V0C for degradation
Qing Yan Liu et al.
MOLECULAR NEURODEGENERATION (2008)
The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin
Y. Jiang et al.
ONCOGENE (2008)
Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs
Yukihiro Tambe et al.
CARCINOGENESIS (2007)
RASSF1C, an isoform of the tumor suppressor RASSF1A, promotes the accumulation of β-catenin by interacting with βTrCP
Emilie Estrabaud et al.
CANCER RESEARCH (2007)
Ras association domain family 1C protein stimulates human lung cancer cell proliferation
Yousef G. Amaar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP
M. Di Benedetto et al.
GENE (2006)
The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth
Jana Divisova et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation
Daiju Kitagawa et al.
EMBO JOURNAL (2006)
RIS1, a gene with trinucleotide repeats, is a target in the mutator pathway of colorectal carcinogenesis
Daniel Iglesias et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis
J Beattie et al.
BIOCHEMICAL JOURNAL (2006)
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
JA Burger et al.
BLOOD (2006)
The RASSF1A tumor suppressor activates Bax via MOAP-1
MD Vos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Ras-association domain family 1 protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation
YG Amaar et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Expression of activated M-Ras in a murine mammary epithelial cell line induces epithelial-mesenchymal transition and tumorigenesis
KR Ward et al.
ONCOGENE (2004)
Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene
JF Li et al.
ONCOGENE (2004)
CXCR4 regulates growth of both primary and metastatic breast cancer
MCP Smith et al.
CANCER RESEARCH (2004)
A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability
MD Vos et al.
CANCER RESEARCH (2004)
Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo
AJ Butt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The human SPANX multigene family:: genomic organization, alignment and expression in male germ cells and tumor cell lines
AJW Zendman et al.
GENE (2003)
Analysis of gene expression profile induced by EMP-1 in esophageal cancer cells using cDNA Microarray
HT Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene
X Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition
O Afonja et al.
ONCOGENE (2002)
Frequent hypermethylation of the RASSF1A gene in prostate cancer
LM Liu et al.
ONCOGENE (2002)
The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation
L Shivakumar et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2)
YG Amaar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1
S Ortiz-Vega et al.
ONCOGENE (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis
K Dreijerink et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas
R Dammann et al.
ONCOGENE (2001)
Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression
DG Burbee et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Key peptide processing enzymes are expressed by breast cancer cells
JL Du et al.
CANCER LETTERS (2001)
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
A Agathanggelou et al.
ONCOGENE (2001)
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
R Dammann et al.
NATURE GENETICS (2000)
Share Paper
